This content is in French.
The IL-1 signaling pathway in bladder cancer
29 février 2024
In bladder carcinoma, there is an imbalance between IL-1 and the IL-1 receptor antagonist. This signaling pathway is therefore of interest for the development of new therapeutic strategies. In this study, we…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Marko Vukovic et al. Interleukin-1β/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive Bladder Cancer-An Exploratory Analysis of Clinical and Tumor Biological Significance. Int J Mol Sci. 2024 Feb 19;25(4):2447.
View the source
